Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...
Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...
Alzheimer’s drugs could unlock a $13 billion market by 2030, with Biogen, Eli Lilly, Novo Nordisk, Roche, and UCB leading the ...
While the Alzheimer’s market is projected to experience strong growth throughout the forecast period across the 8MM, unmet ...
Effectively treating and preventing this common form of dementia will require a cocktail of drugs and a combination of ...
There’s intriguing news today about a technology that could improve treatment in people with Alzheimer’s. It uses sound waves ...
Several recent studies have suggested HRT is a risk factor in various conditions, notably Alzheimer's - now UK boffins have ...
As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...
For decades, scientists have been trying to develop therapeutics for people living with Alzheimer’s disease, a progressive ...
Nearly 7 million Americans have been diagnosed with dementia, which slowly erodes memory, thinking skills and the ability to ...
Groundbreaking research reveals how a cancer drug could restore brain function in early Alzheimer's patients by targeting glucose metabolism. Here's what you need to know.
People suffering from the early onset of Alzheimer's disease are being given access to a revolutionary drug that's being hailed as a potential cure. The drug, Xanamem, works by blocking the ...